A Clinical Study Comparing Superior Capsule Reconstruction Using Different Graft for Irreparable Rotator Cuff Tear
NCT ID: NCT04587037
Last Updated: 2020-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
25 participants
INTERVENTIONAL
2020-10-31
2023-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Superior Capsular Reconstruction Versus. Partial Repair for Irreparable Rotator Cuff Tears
NCT04584476
Arthroscopic Superior Capsular Reconstruction With Fascia Lata Autograft - Survivorship of the Autograft Analysis
NCT03663036
The Cross-sectional Area of the Long Head of the Biceps Tendon and the Rotator Cuff Tear Position
NCT05477771
Safety and Efficacy of Rotator Cuff Function Restoration Balloon in Irreparable Rotator Cuff Tear
NCT04538001
Clinical Study on the Safety and Efficacy of Tendon Stem Progenitor Cells Therapy for Rotator Cuff Tears
NCT07320378
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fascia lata group
fascia lata allograft
underwent superior capsule reconstruction using fascia lata allograft
Dermal allograft group
human dermal allograft
underwent superior capsule reconstruction using human dermal allograft
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fascia lata allograft
underwent superior capsule reconstruction using fascia lata allograft
human dermal allograft
underwent superior capsule reconstruction using human dermal allograft
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Underwent superior capsule reconstruction using fascia lata allograft with human dermal allograft
* At least two years follow-up
Exclusion Criteria
* underwent partial repair or reverse total shoulder arthroplasty
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Jishuitan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chunyan Jiang
Director of Sports Medicine Service of Beijing Jishuitan hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chunyan Jiang
Role: PRINCIPAL_INVESTIGATOR
Sports Medicine Service, Beijing Jishuitan hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CJiang-SCR Compare
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.